Botulinum Toxin Injection for Masseteric Hypertrophy Using 6 Point Injection Technique – A Case Report. Proposal of a Clinical Technique to Quantify Prognosis
DOI: https://doi.org/10.2147/CCIDE.S396057
2023-03-22
Clinical, Cosmetic and Investigational Dentistry
Abstract:Neha N Rathod, Rubin S John Department of Oral and Maxillofacial Surgery, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, 600077, India Correspondence: Rubin S John, Department of Oral and Maxillofacial Surgery, Saveetha Dental College and hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, 600077, India, Email Introduction: Masseter hypertrophy presents as unilateral or bilateral swellings over the ramus and angle of the mandible. It is caused by malocclusion, clenching, TMJ disorders, etc and alters facial symmetry, leading to discomfort and negative cosmetic impact in many patients, making this a popular request for aesthetic and functional correction. Materials and Methods: This case report involves injecting Botulinum toxin into 6 equidistant bulging points on the masseter. Standardized photography and clinical parameters were used to assess facial contour and masseter muscle thickness at baseline and successive follow ups. Results and Discussion: Significant masseteric bulk reduction was observed in subsequent follow ups. Conclusion: The 6-point technique was found to be an effective treatment modality for Botox injection in masseteric hypertrophy. The clinical method to quantify prognosis was easy and economical. Keywords: botulinum, hypertrophy, injection, masseter, toxin The masseter muscle is one of the chief muscles of mastication. The width and volume of this muscle is set particularly by the biting force, chewing habits, type of food, diet, or para-functional habits like bruxism and other temporo-mandibular joint disorders. Any of these can lead to masseter muscle hypertrophy (MMH), which provides a squarish appearance to the face or to the jawline. 1 It is an idiopathic, benign, uncommon condition characterized by unilateral or bilateral enlargement of the masseter muscle and perhaps accompanied by pain, which is often confused with parotid swelling. Hence this swelling is a concern for facial disfigurement. There are two treatment approaches: surgical and non-surgical. Surgical options include surgical reduction of the angle of the mandible and liposuction of the subcutaneous fat. Nonsurgical management includes use of anti-anxiety drugs, muscle relaxants, occlusal equilibration by splints/night guards and injecting botulinum toxin-A (Botox) locally into the hypertrophied muscle. Treatment approach varies from case to case and additionally from the type of prominence of mandibular angle. Type I is when the enlargement is mainly due to muscle hypertrophy and can be appreciated when viewed from the front but appears normal when viewed from the lateral aspect. In such cases, Botox is recommended rather than a surgical method. Type II is when the swelling owes mainly to prominence of angle and not much to hypertrophy of masseter muscles. Botox can be used for re-contouring the face in such cases. Type III is due to both thick mandibular angle and hypertrophy of masseter muscles and it can be appreciated from the frontal and lateral view as well. Both muscle and bone being the cause, it can be resolved by surgery in conjunction with Botox injection. 2 Botox (botulinum toxin) is a neurotoxin produced by the microorganism Clostridium botulinum. It causes flaccid paralysis induced by inhibiting acetylcholine release. 3 This therapeutic effect continues for 3–6 months; within that period, it corrects the patterns of muscle exercises, decreases the squarish appearance of the jaw and alleviates pain by changing the patient's lifestyle. 4 Complications of injecting botulinum toxin include pain, edema, hematoma, chewing weakness, asymmetry, headache, paralysis of facial muscles due to accidental injection to major nerves, neuropraxia due to injury to marginal mandibular nerve, etc. 5 The effectiveness can be evaluated using photographic evaluation, clinical measurements as well as advanced aids like ultrasound, electromyography, CBCT and MRI. A 26-year-old male reported to the clinic seeking cosmetic treatment because he was not happy with the appearance of his face. The patient confirmed a history of clenching and waking up everyday with a headache. Upon inspection, he had a square-shaped lower face with prominence at mandibular angle. When the patient was asked to clench his teeth, the prominence was increased. Upon palpation, abnormal thickening of masseter muscle (triple bulging Type IV, according to the classification given by Xie et al 2014) was observed. He was diagnosed with masseteric hypertrophy Type II, as classified by Kwon et al 2019. 6 He wanted to opt for a non-surgical and minimally inva -Abstract Truncated-